| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
Abate Kristin is a Chief Accounting Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $200K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 50 | $7.03 | $351.50 | -0.2% | +24.3% | - | |
| Jan 21, 2026 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 265 | $5.96 | $1,579.40 | -1.2% | - | - | |
| Oct 1, 2025 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 362 | $6.30 | $2,279.15 | -3.5% | +17.7% | - | |
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 23 | $6.43 | $147.89 | -0.2% | +7.2% | - | |
| Sep 3, 2025 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 12 | $6.78 | $81.36 | -0.1% | -24.3% | - | |
| Jul 22, 2025 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 238 | $4.00 | $952.00 | -2.5% | +66.3% | - | |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | Chief Accounting Officer | Sell | 571 | $6.29 | $3,591.59 | -5.6% | -35.3% | +43.1% |